{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:24:08Z","timestamp":1791869048283,"version":"4.3.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005075","name":"Universitair Medisch Centrum Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1136\/ijgc-2022-004122","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T11:00:17Z","timestamp":1674039617000},"page":"619-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: GROningen INternational Study on Sentinel nodes in Vulvar cancer III (GROINSS-V III\/NRG-GY024)"],"prefix":"10.1016","volume":"33","clinical-trial-number":[{"clinical-trial-number":"nct05076942","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6558-3337","authenticated-orcid":false,"given":"Lilian T","family":"Gien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Slomovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ate","family":"Van der Zee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Oonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2022-004122_bb0010","unstructured":"National Cancer Institute . Surveillance, epidemiology, and end results program. Available: http:\/\/seer.cancer.gov\/statfacts\/html\/vulva.html"},{"key":"10.1136\/ijgc-2022-004122_bb0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ygyno.2013.07.082","article-title":"A review of complications associated with the surgical treatment of vulvar cancer","volume":"131","author":"Wills","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-004122_bb0020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2007.14.0566","article-title":"Sentinel node dissection is safe in the treatment of early-stage vulvar cancer","volume":"26","author":"Van der Zee","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2022-004122_bb0025","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1200\/JCO.2011.41.2528","article-title":"Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study","volume":"30","author":"Levenback","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2022-004122_bb0030","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/IGC.0000000000000975","article-title":"European Society of Gynaecological Oncology guidelines for the management of patients with vulvar cancer","volume":"27","author":"Oonk","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004122_bb0035","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S1470-2045(10)70104-2","article-title":"Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study","volume":"11","author":"Oonk","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2022-004122_bb0040","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1200\/JCO.21.00006","article-title":"Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II","volume":"39","author":"Oonk","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2022-004122_bb0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ygyno.2015.03.056","article-title":"Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis","volume":"137","author":"Gill","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-004122_bb0050","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2022-004122_bb0055","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ygyno.2004.11.007","article-title":"Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group\/Southwest Oncology Group\/Radiation Therapy Oncology Group trial","volume":"96","author":"Monk","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-004122_bb0060","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0360-3016(00)00762-8","article-title":"Preoperative chemo-radiation for carcinoma of the vulva with N2\/N3 nodes: a Gynecologic Oncology Group study","volume":"48","author":"Montana","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2022-004122_bb0065","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0360-3016(00)00569-1","article-title":"Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva","volume":"47","author":"Han","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2022-004122_bb0070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2011.11.003","article-title":"A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study","volume":"124","author":"Moore","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-004122_bb0075","article-title":"Chemoradiation for advanced primary vulval cancer","volume":"2011","author":"Shylasree","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2022-004122_bb0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0959-8049(01)00352-5","article-title":"Chemoradiotherapy for cervical cancer","volume":"38","author":"Rose","year":"2002","journal-title":"Eur J Cancer"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2402440X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2402440X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2022-004122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:28:50Z","timestamp":1753234130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2402440X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1048891X2402440X"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2022-004122","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: GROningen INternational Study on Sentinel nodes in Vulvar cancer III (GROINSS-V III\/NRG-GY024)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2022-004122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}